Ever since humans first came into being in this planet, the human body has evolved to a highly complicated and organized organism consisting of all necessary parts (organs) governed by the brain with unbelievably advanced intelligence, in a sense like an ultra-sophisticated, bio-intelligence-bearing super computer system, which is running uninterruptedly day and night during its whole lifespan. The human brain possesses various innate programs just like the softwares installed in a computer; it performs dynamic processing on various bio-feedback signals it continuously receives, and subsequently sends commands to various organs of the body which work independently but interactively in a precisely coordinated manner according to the inherent physiological programs in the brain. The program for regeneration and rejuvenation of the aged and damaged organs is merely one of thousands of such intrinsic programs imprinted in human brain. After sensing the signals about injuries occurred in organs, the brain will immediately switch the relevant program on to facilitate the regenerative and repairing processes in the damaged organs.
Bioboosti is a signal simulation and generation center for the activation of the regeneration program for the aged and damaged human organs. To date, Bioboosti has developed several sets of coding signals for cardiovascular and nervous regeneration. These coding signals are capable of switching on the intrinsic programs for cardiovascular and neurological regeneration and rejuvenation to recover the damaged cardiovascular and neurological tissues and to retard the aging process of these systems, achieving the goal of self-recovering from disease and life reviving from poor health conditions.
One of the largest organ systems in the human body is the circulation system constituted by heart and a large network of vessels. By arousing the inherent cardiovascular regeneration program in the brain to activate the vascular endothelial cells, Bioboosti helps building new vessels in the human body, thereby improving and restoring the normal blood supply to the entire body. The research data on Bioboosti collected by the researchers in the School of Pharmacy, Fudan University, Shanghai, clearly demonstrated that after eight-minute stimulation with Bioboosti, the growth rate of the cultured human vascular endothelial cells was increased up to 25%. A substantial drop in the blood pressure was observed in the Spontaneously Hypertensive (SHR) rats following three-day treatment with Bioboosti. Similar beneficial effects have also been consistently seen in rat models of cardiac arrhythmias and myocardial infarction. The results from our clinical trials showed that bradycardia, tachycardia and premature ventricular beats were suppressed in 95% of the patients who had received Bioboosti treatment for 7 to 15 days. A clinical report by the Xinhua Hospital of Shanghai Jiao Tong University revealed that after 30-day therapy with Bioboosti, the beats with abnormally prolonged R-R interval of the patients with sick sinus syndrome dropped from 17,380 to 318 times with 24-hour holter. After 30- to 60-day treatment, the cardiac electrophysiological function in 92% of the patients with myocardial ischemia and infarction recovered significantly. The eminent anti-inflammatory efficacy of Bioboosti has also been demonstrated in laboratory research as well as clinical practice. For instance, it has strong efficacy in reducing the level of an inflammatory factor C-reactive protein (CRP) during heart attack and in activating the immune leukocytes. Bioboosti effectively improves micro-circulation by promoting angiogenesis of the capillary vessels. It is also the most effective therapeutic approach for microcirculation disorders such as sexual dysfunction and varicose veins. Bioboosti can promote the regeneration of injured blood vessels and improve blood supply in a short period of time free from pain and without the need for surgery and medication. With the success of this therapeutic approach, the treatment of cardiovascular diseases will surely and rapidly advance in the new direction featuring the regeneration of damaged vascular tissues. Bioboosti has the regeneration capacity for the damaged nervous system and clinical trials have proven its effectiveness in the rehabilitation of patients with hemiplegia and stroke.
Bioboosti was jointly developed, based on the Biological Electromagnetic (BEM) microbial wave technology of the Pulsed Electromagnetic Field Therapy (PEMF), by the experts in biological and biochemical sciences, electronics and integrated circuits, communication systems engineering, and various medical disciplines from the Biomobie Experimental Center in USA. Drawing upon constant exploration by scientists of the older generation for nearly a half century, Bioboosti has ultimately pushed the BEM microbial wave biotechnology of the PEMF into a new stage for practical use. Just like the way how the first generation IBM huge and bulky computers evolved into today's personal digital assistant (PDA), the Biomobie research team based in the Silicon Valley of the United States has succeeded, after years of numerous experiments and constant system upgrading, in the development of Bioboosti system with the capability and capacity for real-time and dynamic regeneration of injured vessel and nerve, viral suppression and disease treatment. This system integrates one control terminal, two supporting terminal database platforms, one communication channel, and one portable intelligent treatment terminal. The control terminal of Bioboosti can be remotely controlled by the medical experts to conduct, through the portable terminal, the classified and individualized regenerative activation, viral suppression, and disease treatment of the damaged tissues. The control terminal of Bioboosti consists of two platforms, i.e. the database platform for regeneration and repairing of damaged organs, which is also known as the “Regeneration Coding Factor Bank”, and the prescription database platform for the inhibition of viral growth and treatment of diseases, which is also known as the “Bio-electronic Pharmaceutics Bank”. These two databases can be accessed by medical experts at any time through PC.
In the Biomobie Experimental Center based in USA, Bioboosti has made a number of gratifying research achievements. In China, Biomobie has been working with other cardiovascular experts from several prestigious universities and medical institutions in an attempt to achieve a larger scale of treatment of cardiovascular disease and to open up a new path towards rehabilitation of the patients suffering from cardiovascular disease and the sub-healthy population as well.
Bioboosti BBT-I, one of Bioboosti series products, is being used as a mobile biological engine for the regeneration of damaged heart and vessels. It can mobilize the dormant vascular endothelial cells to proliferate so as to grow new capillary tissues to meet the demand of the blood supply to the heart. Bioboosti BBT-I offers self-healing therapy without the need for surgery and medication and free of pain and toxic side effects, which enables rapid restoration of the inherent cardiovascular blood supply within 30 days of treatment to rectify the symptom of cardiovascular diseases. Bioboosti BBT-I is a cardiovascular regeneration product of Bioboosti regeneration factor bank of the Biomobie company with a small size of a walnut. It is a brand new bio-regeneration technology product of the 21st century, with which the human body can effectively activate the regeneration program for the cardiovascular endothelial cells to achieve the goals of treatment and prevention of cardiovascular diseases and even cure of cardiac disease and hypertension.
1. A patient diagnosed with cardiac disease will be subject to cardiovascular examinations and data collection in Bioboosti Center and be invited to sign up for a membership associated with Bioboosti Center.
2. A personalized regimen will be formulated for Bioboosti BBT-I microbial wave treatment and the initial on-site dynamic treatment will be carried out on the patient.
3. The patient will leave Bioboosti Center. The patient will be instructed to hold the BBT-I in palm for 8-32 minutes every day whenever it is convenient in a day. After 7-45 days of optimized treatment which is dynamically and remote controlled by Bioboosti Center, new capillaries will be regenerated within the heart and the symptoms of myocardial ischemia will be quickly rectified, resulting in prevention and treatment of cardiovascular diseases. After a 45-day therapeutic period, the patient will be called to revisit Bioboosti Center for re-examination to confirm the anticipated outcome. The patient then will have the option to continue the treatment for other diseases, if any, or the lifelong anti-aging therapy. It is highly recommended that the patient palm-hold Bioboosti once a day to keep his blood vessels young and to achieve healthy longevity.
4. Every year, Bioboosti Center will perform an assessment on the therapeutic outcomes of Bioboosti for each patient and develop a new anti-aging program for the members.
The magnetic field of the Earth is dynamic, which serves as one of the most fundamental elements for the mankind to survive in this planet. Humans acquire through this dynamic magnetic field the biological energy and biological current necessary for the growth of bones, muscles and other organs. The fact that the NASA astronauts, who had been otherwise healthy when leaving our planet to the astrospace, suffered from osteoporosis and muscle atrophy after they returned to the earth verifies the dynamic magnetic field as a basic element for human survival.
Conversion of the Earth magnetic field into bioelectricity is a natural process for the growth of organisms. Based upon this fact and through precise computation and enormous statistical analysis of experimental data, Bioboosti has been able to decode the electromagnetic (current) intensity, frequency and waveforms essential to the regeneration and repairing of damaged cardiovascular tissues. The parameters of this biological regeneration electromagnetism (converted into current coding signals in the body) are limited to a rather narrow window for effective therapy. Parameters not falling within this effective range are not able to activate the regeneration of the damaged cardiovascular tissues. Similar to the magnetic field of the Earth, the biological regeneration electromagnetism of Bioboosti is the microbial magnetism necessary for the regeneration of the human heart and vessels. It is completely different from the high-frequency electromagnetic waves generated for the telecommunications in terms of their electromagnetic properties. The energy consumption of Bioboosti is significantly lower than that of a cell phone.
The magnetic field emitted by Bioboosti belongs to PEMF. According to the Guidelines of the International Committee on Non-Ionizing Radiation Protection (ICNIRP), PEMF will not produce any physiologically and psychologically adverse effects to the human body, and to embryonic development and postnatal development of the mammals；neither will it cause teratogenesis and tumorigenesis.
The strength the magnetic field generated by Bioboosti is only 0.22 mT, a value significantly lower than the safety threshold value (200 mT) and even lower than the minimum value (0.5 mT) for monitoring, according to the Technical Guidelines on the Registration of Magnetic Therapy Products stipulated by the State Food and Drug Administration. Bioboosti is in no doubt safe for the human body!
The biological micro-current signal generated in the human body by Bioboosti is a stimulus to the regeneration signal naturally produced in the human body with injury, which can activate the rejuvenation and regeneration of the human cardio-cerebrovascular endothelial cells. “After the birth, the human body is full of young vascular endothelial cells releasing sufficient NO in blood vessels. This is why children are not prone to cardiac diseases. The growth of the human tissues reaches the peak after the age of 35 with NO release reducing rapidly. In order to maintain cardiovascular health, the human must increase the NO release every day and maintain cardiovascular health through the inherent anti-vascular disease mechanism.” Quoted by Dr. Ignarro, 1998 Nobel Prize winner in Medicine. There is no over-dose problem in the long-term use of Bioboosti. On the contrary, Biomobie recommends long-term use of Bioboosti to maintain sufficient production/release of NO. No side effects were noticed in a four-year clinical trial on Bioboosti with the participation of thousands of volunteers.